Language

News topic

Active ingredient Secukinumab

Current shortage notices for the active ingredient Secukinumab, structured by product, country and reporting period.

2 notices

← All shortages

Belgium

Cosentyx 300 mg inj. sol. s.c. pre-filled pen 3 x 2 ml

Active ingredient: Secukinumab

View notice details →
Belgium

Cosentyx 300 mg inj. opl. s.c. voorgev. pen 3 x 2 ml

Active ingredient: Secukinumab

View notice details →